echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > The progress of new drugs is injected once every two months!

    The progress of new drugs is injected once every two months!

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the U.
    S.
    Food and Drug Administration (FDA) approved the Apreude (cabotegravir sustained-release injection suspension ) developed by ViiV Healthcare, a GlaxoSmithKline holding company , for pre-exposure prevention in high-risk adults and adolescents weighing at least 35 kg.
    To reduce the risk of sexual infection with HIV .
    The administration of Apreude is started with two injections a month apart , and then once every two months .

    Recently, the U.


    S.
    Food and Drug Administration (FDA) approved the Apreude (cabotegravir sustained-release injection suspension ) developed by ViiV Healthcare, a GlaxoSmithKline holding company , for pre-exposure prevention in high-risk adults and adolescents weighing at least 35 kg.


     According to the 2021 Global AIDS Prevention and Control Progress Report, there will be 1.


    5 million new HIV infections globally in 2020, a 31% decrease compared with 2010


    Pre-exposure prophylaxis (PrEP) is a preventive treatment for HIV, which can be understood as “pre-treatment”, mainly for HIV-negative individuals who are at high risk of HIV infection.


    End

    Reference materials:

    Reference materials:

    [1] https:// nouncements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention

    [1] https:// nouncements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention https:// -events/press-an nouncements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.